戻る Agenda
Session 9: Building AI and Machine Learning Innovations for Credible Real-World Evidence Generation
Session Chair(s)
Representative Invited
GlaxoSmithKline, United States
Representative Invited
AstraZeneca, United States
Session 9: Building AI and Machine Learning Innovations for Credible Real-World Evidence Generation
Speaker(s)
Representative Invited
Founder, Black Swan Causal Labs, United States
Operationalizing AI Governance for RWE: A Comparative Analysis of Regulatory, HTA, and Specialty Bodies
Representative Invited
Director, Johnson and Johnson Innovative Medicine, United States
Establish Credibility for AI Enabled Real World Evidence in Regulatory Decision Making: From Promise to Practice